Cargando…

Melatonin Attenuates Cardiac Reperfusion Stress by Improving OPA1-Related Mitochondrial Fusion in a Yap–Hippo Pathway–Dependent Manner

The role of OPA1-related mitochondrial fusion in cardiac reperfusion stress has remained elusive. The aim of our study is to explore whether melatonin alleviates cardiac ischemia-reperfusion (IR) injury by modulating OPA1-related mitochondrial fusion. We found that melatonin reduced infarct area, su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shuxian, Dong, Zhenming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319588/ https://www.ncbi.nlm.nih.gov/pubmed/30418242 http://dx.doi.org/10.1097/FJC.0000000000000626

Ejemplares similares

Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway
por: Zhao, Xiaoguang, et al.
Publicado: (2018)

Melatonin Attenuates Calcium Deposition from Vascular Smooth Muscle Cells by Activating Mitochondrial Fusion and Mitophagy via an AMPK/OPA1 Signaling Pathway
por: Chen, Wei Ren, et al.
Publicado: (2020)

Melatonin Attenuates Ischemia/Reperfusion-Induced Oxidative Stress by Activating Mitochondrial Fusion in Cardiomyocytes
por: Ma, Xiaoling, et al.
Publicado: (2022)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Pterostilbene attenuates microglial inflammation and brain injury after intracerebral hemorrhage in an OPA1-dependent manner
por: Wu, Yang, et al.
Publicado: (2023)

Retracted: Melatonin Attenuates Ischemia/Reperfusion-Induced Oxidative Stress by Activating Mitochondrial Fusion in Cardiomyocytes
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
por: Wang, Yan, et al.
Publicado: (2021)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology
por: Chen, Xiaoqing, et al.
Publicado: (2020)

Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1(+/-) Mouse Model
por: Le Page, Sophie, et al.
Publicado: (2016)

Empagliflozin improves renal ischemia–reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK–OPA1 pathway promotion
por: Yang, Wenbo, et al.
Publicado: (2023)

PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway
por: Gu, Jiayi, et al.
Publicado: (2019)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

RRM2 Improves Cardiomyocyte Proliferation after Myocardial Ischemia Reperfusion Injury through the Hippo-YAP Pathway
por: Yu, Huamin, et al.
Publicado: (2021)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
por: Wang, Shuai, et al.
Publicado: (2020)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

Hippo-Yap Pathway Orchestrates Neural Crest Ontogenesis
por: Zhao, Xiaolei, et al.
Publicado: (2021)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
por: Lo Sardo, Federica, et al.
Publicado: (2017)

MCU Up‐regulation contributes to myocardial ischemia‐reperfusion Injury through calpain/OPA‐1–mediated mitochondrial fusion/mitophagy Inhibition
por: Guan, Lichun, et al.
Publicado: (2019)

Two forms of Opa1 cooperate to complete fusion of the mitochondrial inner-membrane
por: Ge, Yifan, et al.
Publicado: (2020)

In situ architecture of Opa1-dependent mitochondrial cristae remodeling
por: Fry, Michelle Y., et al.
Publicado: (2023)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

Clinical implications of the Hippo-YAP pathway in multiple cancer contexts
por: Kim, Han-Byul, et al.
Publicado: (2018)

The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
por: Rognoni, Emanuel, et al.
Publicado: (2019)

The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
por: Mo, Jung-Soon
Publicado: (2017)

YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango
por: Matthaios, Dimitrios, et al.
Publicado: (2021)

Melatonin attenuates doxorubicin‐induced cardiotoxicity through preservation of YAP expression
por: Li, Hai‐ru, et al.
Publicado: (2020)

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
por: Qi, Yangfan, et al.
Publicado: (2016)

OPA1’s shortcut to mitochondrial fission
por: Short, Ben
Publicado: (2014)

The Hippo-YAP Pathway Regulates 3D Organ Formation and Homeostasis
por: Ishihara, Erika, et al.
Publicado: (2018)

Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy
por: Fodor, Lili E., et al.
Publicado: (2017)

Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
por: Santos-de-Frutos, Karla, et al.
Publicado: (2019)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3rq486vi43k5bu5hktcs82o08